Literature DB >> 33569221

Robotic bronchoscopy: is it classic?

Taichiro Goto1.   

Abstract

Year:  2021        PMID: 33569221      PMCID: PMC7867816          DOI: 10.21037/jtd-20-3088

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
I read with interest the paper titled “Robotic bronchoscopy for pulmonary lesions: a review of existing technologies and clinical data” by Agrawal et al. (1). This article reviewed the existing robotic bronchoscopy technologies and summarized the available pre-clinical and clinical data supporting their use. Robotic bronchoscopy was reported to have achieved successful lesion localization in 96.2% of cases, with an adverse event rate comparable to those of conventional bronchoscopic procedures (2). However, its diagnostic yield in sampling peripheral lung lesions remains yet to be demonstrated. I wish to discuss the implications of this review article and prospects for robotic bronchoscopy from the perspective of a thoracic surgeon. Robotic surgery has been widely adopted for mainly prostate surgery, and it can be safely said that nearly all cases of prostate surgery at present are robot-assisted (3). In robotic prostate surgery, dexterity and visualization are improved, while invasiveness is minimized; compared with open surgery, robotic surgery is safer and easier to perform (4). Because of these clear advantages, robotic prostate surgery is widely adopted. However, robotic cardiac surgery is not common in Japan even though it is covered by the National Health Insurance; the widespread adoption of robotic surgery might depend on whether the aforementioned advantages can be realized for cardiac surgery. Then, what are the benefits of robotic bronchoscopy? In conventional bronchoscopy, surgeons are challenged by the narrow airways and complexities of the bronchial tree, which sometimes deter access to tumors (5). Although the procedural safety of robotic surgery has been ensured by compensating for the loss of tactile sense using a close, magnified view, is a similar strategy applicable to robotic bronchoscopy? Is the observable range (operable range) of robotic bronchoscopy more extensive in inherently narrow airways than that of conventional bronchoscopy? Should large-scale studies on robotic bronchoscopy, which entails no sensation of touching the airway epithelium, necessarily include some patients with airway trauma? In fact, a study involving 165 patients reported that airway bleeding occurred in 2.4% of the patients (6). With regard to the emergency treatment of biopsy-related bleeding, can the bronchoscope be safely wedged into the segmental bronchus responsible for the hemorrhagic focus without tactile sensation at the bronchoscope tip? I hope that in the future, the safety of robotic bronchoscopy will be verified in a broader scope, such as by considering emergency responses. Furthermore, in the future, prospective comparative studies should be conducted with diagnostic yield as the primary endpoint, with complications, procedural time, patient stress evaluations, and radiation exposure doses as the secondary endpoints. Robotic bronchoscopy has wide applicability; further reduction of the scope diameter and more flexible maneuverability of the scope head may enable operations even in the branching patterns, which are difficult to navigate manually. In addition, I am personally hopeful that robotic surgical systems will acquire higher multifunctionality; the availability of functions such as a wiper system for cleaning the scope lens, visualization and recording systems for the surrounding and posterior views, a self-driving system that autonomously operates the fiberscope with guidance from a navigation system, a collision-avoidance system that always maintains the fiberscope at the center of the airway, and an emergency aid system that inflates an airway balloon in the event of bleeding can help increase the popularity of robot-assisted bronchoscopy. In addition, if total automation and remote control are available, then aerosol avoidance during bronchoscopy may contribute toward effective prevention of nosocomial infection by pathogens such as the recent coronavirus (COVID-19) (7). Further, what do bronchoscopists expect from further improvements to robotic bronchoscopy? Although the benefits of robotic bronchoscopy may be limited in the current scenario, this review article has suggested its safety and clinical applicability as an important first step toward future development. I expect that, along with the parallel development and promotion of new technologies and their validation through clinical trials, robotic bronchoscopy could be established as a new clinical standard within the next 10 years, similar to the da Vinci robotic prostate surgery. The article’s supplementary files as
  1 in total

1.  The Diagnostic Utility of Cell-Free DNA from Ex Vivo Bronchoalveolar Lavage Fluid in Lung Cancer.

Authors:  Sotaro Otake; Taichiro Goto; Rumi Higuchi; Takahiro Nakagomi; Yosuke Hirotsu; Kenji Amemiya; Toshio Oyama; Hitoshi Mochizuki; Masao Omata
Journal:  Cancers (Basel)       Date:  2022-03-30       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.